Bio-based intelligent solutions -collaboration platform strengthening regional circular economy
BioÄly project – Objectives and Results:
– Creating industry initiated product and service concepts, and pilots/demonstrations in collaboration with industrial partners.
– Building a collaboration platform for bio-based intelligent solutions supporting bio- and circular economy.
– Creating knowledge and knowhow pool about available technologies with linked experts on the areas.
– Collaboration platform enables new business models and building of the value chains.
The main goal is to create a bio-based intelligent solutions collaboration platform within the timeframe of the project. The network is built around intelligent bio-based solutions that enhance the collaboration between different parties of the network. This interdisciplinary project combines expertise from modern electronics, materials and packaging technology, nano and biomaterials, process chemistry and value analysis in circular economy. The project targets to create preconditions for long-term, evolving and appealing collaboration network.
The target is to create an operational principle of the collaboration network that is piloted and developed with the help of the state-of the-art scientific knowledge. Main outcome of the project is open and active innovation collaboration network for bio and circular economy in the Pirkanmaa region. The target is that the network will continue in function also after the project benefiting the collaboration platform members.
European Regional Development Fund
Senior Research Fellow / Coordinator
+358 40 849 0156
+358 40 771 2772
+358 40 849 0990
Functional human cell based cardiovascular model for biomedical research and testing (InVitroCardioModel)
The project is funded by the Academy of Finland is a consortium project between Tuula Heinonen’s group at FICAM and Sampo Tuukkanen’s group at Tampere University. Project description: Animal models are widely used in research and industry to test cardiac side effects and cardiotoxicity of new drug molecules and other chemicals as well as to be used in cardiac drug development.
Due to the physiological and functional differences between species the results are not necessarily applicable to humans. Therefore standardized cellular models similar to human situation are urgently needed.
The main object of this project is to develop human like cardiovascular model based on human pluripotent stem cell derived cardiomyocytes that are combined with the human cell based vascular platform. An integrated sensor and measurement system for monitoring of the physico-chemical parameters, beating frequency, QT interval and beating force will be developed. The developed model system would be widely applicable to assessment of toxicity, adverse effects and efficacy and to be used as useful tool in biomedical research. Further it can be modified to specific cardio disease models.
Academy of Finland
+358 50 574 9705
+358 40 541 5276